Innovation Igniter shares the top industry news highlights for medical product development, industrial design and more. This week, we cover the rise in digital therapeutics, Cintrifuse CEO Wendy Lea’s take on minorities and women in tech – and on the first minority-focused accelerator in the Midwest, and the story of a man who wound up being one of the first users of the knee implant system he helped design.

medical product development

The FDA just approved the first app for treating substance abuse

The FDA recently approved the first app intended to help treat substance abuse problems, opening the door for future apps with similar missions to likewise enter the market. The approved app was designed by digital therapeutics startup Pear Therapeutics, and employs the use of cognitive behavioral therapy (CBT). The app was made to be prescribed by a physician and used alongside counseling services.

The results of a 12-week trial prior to the FDA’s approval showed the app had a statistically significant increase in adherence to abstinence from alcohol, cocaine, marijuana and stimulants.

“This is the moment for digital therapeutics,” said Pear Therapeutics Founder and CEO Corey McCann.

medical product development

Women In Tech: An Interview With Wendy Lea

Wendy Lea, CEO of the Cincinnati-based startup catalyst Cintrifuse, opened up about the “bro culture” within the tech community and how Cintrifuse is playing a role in bringing more diversity into the tech culture through the Hillman Accelerator, the first minority-focused accelerator in the Midwest.

Cintrifuse, a 38,000-square foot space based in the neighborhood of Over the Rhine, is a public/private partnership that aims to build a sustainable tech-based economy in the Greater Cincinnati region. Cincinnati has risen in the Kauffman Index Study on Startup Activity to the 16th spot for metropolitan areas.

medical product development

“I Designed my Knee Replacement”: Meet the Johnson & Johnson Employee Who Benefited from his own Innovation

Depuy Synthes (part of Johnson & Johnson) product designer Dan Rumple worked on the Attune® Knee System, which is designed to function like a real joint. The latest version (in limited launch in the U.S., as of the June 28, 2017 article) is a cementless knee implant system designed to optimize initial bonding to the bone without cement, with the bone ultimately growing into the porous surface of the replacement knee.

Dan Rumple shared his story of how he needed a knee replacement and was one of the first to use the new system he helped design.


Our Authors: Matt Suits and Andreya Carlson

About The Author: Matt Suits

Matt has always loved interacting with clients to find solutions for their challenges. He was drawn to business development at Kaleidoscope because of the great potential he saw. After graduating from the Lindner College of Business at the University of Cincinnati, he worked with two startups, a marketing consultancy, a financial services company and the non-profit 3CDC. He believes that listening is the most important part of sales. In his free time, Matt enjoys movies, trying new foods, traveling and the great outdoors.

About the Author: Andreya Carlson

Andreya has always been fascinated by language and the written word, which drove her to earn a degree in Journalism from the E.W. Scripps School of Journalism at Ohio University. She additionally earned a degree in Psychology, which kindled her interest in the healthcare industry. Her experience in marketing, communications, writing and editing includes work with a prominent human rights organization in England and a Cincinnati-based book publishing company. Andreya’s appetite for knowledge and passion for purposeful creation led her to cover design and healthcare advancement news for Kaleidoscope.

Industrial Design Firm Consulting Contact Us